Global Pharmaceutical Quality Control Market Size Study, by Product (Consumables, Instruments, Services), by Analysis Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing, Raw Material Testing,

Global Pharmaceutical Quality Control Market Size Study, by Product (Consumables, Instruments, Services), by Analysis Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Stability Testing, Extractable & Leachable Testing, Raw Material Testing, Others), by Products Tested (Vaccines, Plasma Products, Drugs) and Regional Forecasts 2022-2032

Global Pharmaceutical Quality Control Market is valued at approximately USD 4.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.21% over the forecast period 2024-2032. The rising costs of drug manufacturing and the increasing need to comply with stringent regulatory requirements are driving the market's growth. In the pharmaceutical sector, manufacturing expenses constitute a significant portion of a company's total costs, and the development costs of new drugs have consistently risen, with investments required for bringing lab-conceived ideas to successful commercialization projected to be around USD 2 billion. Moreover, Pharmaceutical companies are heavily regulated to ensure consumer health and safety, necessitating adherence to numerous quality standards. Small and mid-sized pharmaceutical businesses are particularly focusing on regulatory compliance to produce high-quality products and remain competitive.

The primary factors driving the pharmaceutical quality control market include the increasing number of accredited clinical laboratories, growing acceptance of third-party quality controls, and a rising preference for external quality assessment assistance. The surge in the prevalence of various diseases worldwide has led to an increased number of laboratory tests, prompting both public and private sectors to expand the number of laboratories. Clinical laboratories need to obtain accreditation from regulatory organizations to conduct diagnostic tests, which assesses their competency and quality systems against established standards, thereby driving market growth. Furthermore, regulatory bodies like the U.S. Food and Drug Administration (FDA) and the International Organisation for Standardisation (ISO) enforce stringent manufacturing practices, further propelling the demand for advanced quality control systems.

The key regions considered for the Global Pharmaceutical Quality Control Market study include North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In 2023, North America dominated the market due to its advanced technological infrastructure, stringent regulatory standards, and significant investment in research and development. The region's robust healthcare system and the presence of major pharmaceutical companies drive the adoption of cutting-edge quality control measures. High standards for drug safety and efficacy, along with a focus on innovation and compliance, contribute to North America's leadership. Additionally, the integration of sophisticated analytical technologies and a strong emphasis on quality assurance practices further enhance its position as a key player in the global Pharmaceutical Quality Control market. Europe holds a healthy market share, driven by significant investments in R&D for the pharmaceutical industry. Furthermore, the Asia-Pacific region is expected to register fastest growth due to the expansion of pharmaceutical businesses, especially in countries like China and India.

Major market players included in this report are:

BioMerieux SA

SGS S.A.

Charles River Laboratories International Inc.

WiXi AppTec

Merck KGaA

Thermo Fisher Scientific Inc.

Toxikon Corporation

Sartorius AG

REMI Group

Perkin Elmer

The detailed segments and sub-segment of the market are explained below:

By Product:

Consumables

Instruments

Services

By Analysis Type:

Sterility Testing

Bioburden Testing

Endotoxin Testing

Stability Testing

Extractable & Leachable Testing

Raw Material Testing

Others

By Products Tested:

Vaccines

Plasma Products

Drugs

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more